Glutamate formiminotransferase deficiency
Glutamate formiminotransferase deficiency is a rare inherited disorder that can affect development.
In the past, researchers recognized a mild form and a severe form of glutamate formiminotransferase deficiency. Researchers have since found people who received a diagnosis of glutamate formiminotransferase deficiency as infants who do not appear to have any related health problems. Researchers are actively working to learn more about this condition.
The signs and symptoms associated with glutamate formiminotransferase deficiency have ranged from mild developmental delays with high urine levels of a molecule called formiminoglutamate (FIGLU) to more severe intellectual disabilities and megaloblastic anemia. Megaloblastic anemia occurs when a person has a low number of red blood cells (anemia) and the remaining red blood cells are larger than normal (megaloblastic).
Other names
Arakawa syndrome 1; FIGLU-uria; Formiminoglutamic acidemia; Formiminoglutamic aciduria; Formiminotransferase cyclodeaminase deficiency; Formiminotransferase deficiency; FTCD deficiency
Inheritance pattern
Autosomal recessive
Related genes
FTCD
Source: MedlinePlus Genetics, U.S. National Library of Medicine.
